glp 1 agonists moa Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action GLP1 Receptor Agonists—Effects beyond Obesity
Description
Commun., vol
Gaspari et al
Liver Int 26(8): 1015-17 Wettergren A et al (1998): Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow
& Clark, A
[DOI] [PubMed] [Google Scholar] 813.Ghosal S., Packard A.E.B., Mahbod P., McKlveen J.M., Seeley R.J., Myers B
20 Inflammation
